Neuropsychiatry of Histaminergic Circuits: Potential Role of Novel H3 Receptor Selective Antagonist/ Inverse Agonist Pitolisant in Prader-Willi Syndrome

Name: Neuropsychiatry of Histaminergic Circuits: Potential Role of Novel H3 Receptor Selective Antagonist/ Inverse Agonist Pitolisant in Prader-Willi Syndrome
SKU: 27235
Price: 30.00 USD
Availability: InStock

$30.00

Want a discount? Become a member by purchasing Psychopharmacology Bulletin Subscription - Individual!

Categories: Psychopharmacology Bulletin, VOL 54 No. 3 Articles – 2024 Tags: histamine, histamine agonists, histamine antagonists, histamine H3 receptor, histamine receptors, neuropsychiatry, pitolisant, prader-willi syndrome, psychopharmacology, wakix

Description

Description

Letter to the Editor

Neuropsychiatry of Histaminergic Circuits: Potential Role of Novel H3 Receptor Selective Antagonist/ Inverse Agonist Pitolisant in Prader-Willi Syndrome

By Beatriz Freitas, Tomas P. Teodoro

Neuropsychiatry of Histaminergic Circuits: Potential Role of Novel H3 Receptor Selective Antagonist/ Inverse Agonist Pitolisant in Prader-Willi Syndrome

Description

Letter to the Editor

Theodore J. Anfinson, MD: Drug Dependence Involving Prednisone:Two Cases and a Review of the Literature

A Pilot Controlled Trial of Bupropion XL Versus Escitalopram in Generalized Anxiety Disorder

Long-Acting Injectable Paliperidone Palmitate: A Review of Efficacy and Safety

Sophie Robert, PharmD – An Open-Label Assessment of Aripiprazole in the Treatment of PTSD

Neuropsychiatry of Histaminergic Circuits: Potential Role of Novel H3 Receptor Selective Antagonist/ Inverse Agonist Pitolisant in Prader-Willi Syndrome

Description

Letter to the Editor

Related products

Theodore J. Anfinson, MD: Drug Dependence Involving Prednisone:Two Cases and a Review of the Literature

A Pilot Controlled Trial of Bupropion XL Versus Escitalopram in Generalized Anxiety Disorder

Long-Acting Injectable Paliperidone Palmitate: A Review of Efficacy and Safety

Sophie Robert, PharmD – An Open-Label Assessment of Aripiprazole in the Treatment of PTSD